These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 20024675)

  • 1. Colloids as a sink for certain pharmaceuticals in the aquatic environment.
    Maskaoui K; Zhou JL
    Environ Sci Pollut Res Int; 2010 May; 17(4):898-907. PubMed ID: 20024675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the interaction between aquatic colloids and pharmaceuticals facilitated by cross-flow ultrafiltration.
    Maskaoui K; Hibberd A; Zhou JL
    Environ Sci Technol; 2007 Dec; 41(23):8038-43. PubMed ID: 18186334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of pharmaceutically active compounds in an urban receiving water: Occurrence, fate and environmental risk assessment.
    Liu J; Dan X; Lu G; Shen J; Wu D; Yan Z
    Ecotoxicol Environ Saf; 2018 Jun; 154():214-220. PubMed ID: 29476970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of various pharmaceutical compounds in water by solid-phase extraction-liquid chromatography-tandem mass spectrometry.
    Zhang ZL; Zhou JL
    J Chromatogr A; 2007 Jun; 1154(1-2):205-13. PubMed ID: 17420027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence and phase distribution of selected pharmaceuticals in the Yangtze Estuary and its coastal zone.
    Yang Y; Fu J; Peng H; Hou L; Liu M; Zhou JL
    J Hazard Mater; 2011 Jun; 190(1-3):588-96. PubMed ID: 21497014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical residues in wastewater treatment works effluents and their impact on receiving river water.
    Zhou JL; Zhang ZL; Banks E; Grover D; Jiang JQ
    J Hazard Mater; 2009 Jul; 166(2-3):655-61. PubMed ID: 19121894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
    Bendz D; Paxéus NA; Ginn TR; Loge FJ
    J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceuticals in freshwater aquatic environments: A comparison of the African and European challenge.
    Fekadu S; Alemayehu E; Dewil R; Van der Bruggen B
    Sci Total Environ; 2019 Mar; 654():324-337. PubMed ID: 30448654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-phase partitioning, ecological risk and fate of acidic pharmaceuticals in a wastewater receiving river: the role of colloids.
    Duan YP; Meng XZ; Wen ZH; Ke RH; Chen L
    Sci Total Environ; 2013 Mar; 447():267-73. PubMed ID: 23391893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence, distribution, and ecotoxicological risk assessment of selected pharmaceutical compounds in water from Lake Victoria, Uganda.
    Nantaba F; Wasswa J; Kylin H; Palm WU; Bouwman H; Kümmerer K
    Chemosphere; 2020 Jan; 239():124642. PubMed ID: 31521936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-phase distribution and risk assessment of endocrine disrupting chemicals in the surface water of the Shaying River, -Huai River Basin, China.
    Huang Y; Xie X; Zhou LJ; Ji X; Gao B; Xu GZ; Li A
    Ecotoxicol Environ Saf; 2019 May; 173():45-53. PubMed ID: 30763810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom.
    Ashton D; Hilton M; Thomas KV
    Sci Total Environ; 2004 Oct; 333(1-3):167-84. PubMed ID: 15364527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selected emerging organic contaminants in the Yangtze Estuary, China: a comprehensive treatment of their association with aquatic colloids.
    Yan C; Yang Y; Zhou J; Nie M; Liu M; Hochella MF
    J Hazard Mater; 2015; 283():14-23. PubMed ID: 25262479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of selected pharmaceuticals in the principal sewage treatment plants in Rome (Italy) and in the receiving surface waters.
    Patrolecco L; Capri S; Ademollo N
    Environ Sci Pollut Res Int; 2015 Apr; 22(8):5864-76. PubMed ID: 25352396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fate and mobility of pharmaceuticals in solid matrices.
    Drillia P; Stamatelatou K; Lyberatos G
    Chemosphere; 2005 Aug; 60(8):1034-44. PubMed ID: 15993150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatiotemporal distribution of pharmaceuticals in the Douro River estuary (Portugal).
    Madureira TV; Barreiro JC; Rocha MJ; Rocha E; Cass QB; Tiritan ME
    Sci Total Environ; 2010 Oct; 408(22):5513-20. PubMed ID: 20732709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sediment-water interactions of pharmaceutical residues in the river environment.
    Zhou J; Broodbank N
    Water Res; 2014 Jan; 48():61-70. PubMed ID: 24091188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of emerging contaminants in sewage effluent and river water: comparison between spot and passive sampling.
    Zhang Z; Hibberd A; Zhou JL
    Anal Chim Acta; 2008 Jan; 607(1):37-44. PubMed ID: 18155407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation of water quality guidelines for priority pharmaceuticals.
    Kumar A; Batley GE; Nidumolu B; Hutchinson TH
    Environ Toxicol Chem; 2016 Jul; 35(7):1815-24. PubMed ID: 26660719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in toxicity and Ah receptor agonist activity of suspended particulate matter during flood events at the rivers Neckar and Rhine - a mass balance approach using in vitro methods and chemical analysis.
    Wölz J; Engwall M; Maletz S; Olsman Takner H; van Bavel B; Kammann U; Klempt M; Weber R; Braunbeck T; Hollert H
    Environ Sci Pollut Res Int; 2008 Oct; 15(7):536-53. PubMed ID: 18936997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.